Logo image of IX1.DE

IDEXX LABORATORIES INC (IX1.DE) Stock Price, Forecast & Analysis

Europe - Frankfurt Stock Exchange - FRA:IX1 - US45168D1046 - Common Stock

595.2 EUR
-8.4 (-1.39%)
Last: 12/22/2025, 7:00:00 PM

IX1.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap47.53B
Revenue(TTM)4.17B
Net Income(TTM)1.03B
Shares79.85M
Float79.30M
52 Week High663.2
52 Week Low349.2
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)10.7
PE55.63
Fwd PE47.44
Earnings (Next)02-02 2026-02-02/amc
IPO1991-06-21
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


IX1.DE short term performance overview.The bars show the price performance of IX1.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 40

IX1.DE long term performance overview.The bars show the price performance of IX1.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30 40 50

The current stock price of IX1.DE is 595.2 EUR. In the past month the price increased by 54.76%. In the past year, price increased by 32.15%.

IDEXX LABORATORIES INC / IX1 Daily stock chart

IX1.DE Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
1MDT.MI MEDTRONIC PLC 17.59 107.77B
2M6.DE MEDTRONIC PLC 17.36 106.36B
SHL.DE SIEMENS HEALTHINEERS AG 18.62 50.20B
PHI1.DE KONINKLIJKE PHILIPS NV 15.41 21.95B
1PHIA.MI KONINKLIJKE PHILIPS NV 15.38 21.92B
PHIA.AS KONINKLIJKE PHILIPS NV 15.36 21.90B
BIM.PA BIOMERIEUX 28.5 13.02B
OBCK.DE OTTOBOCK SE & CO KGAA 137.87 4.15B
DIA.MI DIASORIN SPA 20.13 3.73B
AFX.DE CARL ZEISS MEDITEC AG - BR 25.03 3.60B
DRW3.DE DRAEGERWERK AG - PREF 10.6 1.28B
ELN.MI EL.EN. SPA 21.7 1.12B

About IX1.DE

Company Profile

IX1 logo image IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.

Company Info

IDEXX LABORATORIES INC

One Idexx Drive

Westbrook MAINE US

Employees: 11000

IX1 Company Website

IX1 Investor Relations

Phone: 12075560300

IDEXX LABORATORIES INC / IX1.DE FAQ

What does IDEXX LABORATORIES INC do?

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.


Can you provide the latest stock price for IDEXX LABORATORIES INC?

The current stock price of IX1.DE is 595.2 EUR. The price decreased by -1.39% in the last trading session.


Does IX1 stock pay dividends?

IX1.DE does not pay a dividend.


What is the ChartMill rating of IDEXX LABORATORIES INC stock?

IX1.DE has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


On which exchange is IX1.DE stock listed?

IX1.DE stock is listed on the Frankfurt Stock Exchange exchange.


What is the employee count for IX1 stock?

IDEXX LABORATORIES INC (IX1.DE) currently has 11000 employees.


IX1.DE Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to IX1.DE. When comparing the yearly performance of all stocks, IX1.DE is one of the better performing stocks in the market, outperforming 92.88% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

IX1.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to IX1.DE. Both the health and profitability get an excellent rating, making IX1.DE a very profitable company, without any liquidiy or solvency issues.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

IX1.DE Financial Highlights

Over the last trailing twelve months IX1.DE reported a non-GAAP Earnings per Share(EPS) of 10.7. The EPS increased by 15.16% compared to the year before.


Industry RankSector Rank
PM (TTM) 24.65%
ROA 30.34%
ROE 65.81%
Debt/Equity 0.53
Chartmill High Growth Momentum
EPS Q2Q%21.43%
Sales Q2Q%13.29%
EPS 1Y (TTM)15.16%
Revenue 1Y (TTM)8.39%

IX1.DE Forecast & Estimates

21 analysts have analysed IX1.DE and the average price target is 687.11 EUR. This implies a price increase of 15.44% is expected in the next year compared to the current price of 595.2.

For the next year, analysts expect an EPS growth of 16.89% and a revenue growth 10.46% for IX1.DE


Analysts
Analysts80.95
Price Target687.11 (15.44%)
EPS Next Y16.89%
Revenue Next Year10.46%

IX1.DE Ownership

Ownership
Inst Owners94.91%
Ins Owners0.21%
Short Float %N/A
Short RatioN/A